Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab and cardiovascular risk factors in rheumatoid arthritis
2010-018658-12Phase 4Completed
- Sponsor
- Fundación Rafael Clavijo
- Start
- Mar 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Fundación Rafael Clavijo. Primary endpoints: Change in cardiovascular risk factors, Change in nutritional status and 6 more. Started Mar 2010; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-018658-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018658-12.